Quent Capital, LLC
- SEC CIK
- 0001912338
- Latest filing
- Aug 7, 2026
APRE holding history
Aprea Therapeutics, Inc. in every 13F filed by Quent Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APRE overviewAll 13F holders of APREFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q1 2023 | 3 | $13 | <0.1% | −1−20.0% | ReducedConverted for a 1-for-20 split | Holders |
| Q4 2022 | 75 | $25 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 75 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 75 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 75 | $0 | 0.0% | +75 | New | Holders |